Advances and novel developments in drug hypersensitivity diagnosis

Area of Science:

• Clinical Immunology
• Pharmacology
• Allergy Diagnostics

Background:

• Accurate diagnosis of drug hypersensitivity reactions (DHRs) is vital for patient care and health systems.
• Current DHR diagnosis is complex, time-consuming, lacks standardization for many drugs, and involves risky procedures.
• There is a significant need for improved diagnostic approaches for suspected DHRs.

Purpose of the Study:

• To review recent advances in the diagnosis of immediate and non-immediate DHRs over the past two years.
• To identify areas for improvement and standardization in DHR diagnostic practices.
• To evaluate the role of in vivo and in vitro testing in enhancing diagnostic accuracy.

Main Methods:

• Analysis of recent literature (last two years) on DHR diagnostic advancements.
• Evaluation of current practices in diagnosing immediate and non-immediate DHRs.
• Assessment of progress in both in vivo and in vitro diagnostic testing.

Main Results:

• Significant heterogeneity exists in current DHR diagnostic practices across different centers.
• Recent studies focus on enhancing the sensitivity and specificity of in vitro tests for new drugs.
• There is a growing consensus on combining in vivo and in vitro tests for optimal diagnostic accuracy.

Conclusions:

• There is a clear need to re-evaluate, update, and standardize in vivo tests and protocols for DHR diagnosis and management.
• Improving the sensitivity and specificity of in vitro tests is an ongoing research focus.
• Combining in vivo and in vitro diagnostic methods is considered the most effective strategy to increase diagnostic accuracy for DHRs.